Patents Assigned to Theriac Biomedical Inc.
  • PPAR-? activators, HDAC inhibitors and their therapeutical usages
    Patent number: 10702488
    Abstract: The invention relates to a composition for induction of activity of a nuclear receptor PPAR? and inhibition of HDAC in a subject in need thereof, which comprises a synergistic combination of benzoate and phenylbutyrate and/or phenylacetate in association with a pharmaceutical carrier.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: July 7, 2020
    Assignee: Theriac Biomedical Inc.
    Inventor: Tony Antakly